Affinity Therapeutics is a research-driven biotech company focusing on the design and delivery of life-enhancing medical applications.
Affinity Therapeutics, LLC was founded to commercialize technology developed at Case Western Reserve University (CWRU). This technology is controlled release of therapeutics using molecular interactions to obtain release rates and durations not available by diffusion alone. By utilizing this platform technology, Affinity is poised to change how therapeutics are delivered in several markets including the advanced wound care and hernia mesh.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 12, 2013 | Grant | $149.99K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |